SCHEMBL4347368

SCHEMBL4347368

NC=CNC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899259 0.75
SCHEMBL1811809 0.75
SCHEMBL7026519 0.75
SCHEMBL20640327 0.75
SCHEMBL28187884 0.73
SCHEMBL17753807 0.73
SCHEMBL3858865 0.73
SCHEMBL285048 0.71
SCHEMBL13725668 0.69
SCHEMBL13075957 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2912045-A2 POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS Molecular Transfer, Inc. (US) 2015-09-02 EP claimed
WO-2014070687-A2 POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2014-05-08 WO claimed
EP-2696678-A1 AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS Molecular Transfer, Inc. (US) 2014-02-19 EP claimed
WO-2013158127-A1 AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2013-10-24 WO claimed
WO-2012142622-A1 AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS MOLECULAR TRANSFER, INC. (US) 2012-10-18 WO claimed
EP-0663013-A1 METHOD FOR DELIVERING NUCLEIC ACIDS INTO CELLS THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 1995-07-19 EP claimed
EP-0663013-A4 METHOD FOR DELIVERING NUCLEIC ACIDS INTO CELLS. UNIV TENNESSEE RES CORP (US) 1994-11-28 EP claimed
WO-1993005162-A1 METHOD FOR DELIVERING NUCLEIC ACIDS INTO CELLS THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 1993-03-18 WO claimed
WO-2024145435-A2 LIPID COMPOSITIONS AND METHODS FOR DELIVERY TO IMMUNE CELLS Life Technologies Corporation (US) 2024-07-04 WO disclosed
WO-2024011118-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BY TARGETING ONCOGENIC TRANSFER RNAS THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2024-01-11 WO disclosed
EP-4175967-A2 TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF Life Technologies Corporation (US) 2023-05-10 EP disclosed
CN-114746124-A Delivery system complexes comprising active agent precipitates and methods of use 北卡罗来纳-查佩尔山大学 2022-07-12 CN disclosed
WO-2022125956-A1 IMMUNOMODULATORY LIPOPOLYSACCHARIDE COMPOSITIONS TRUSTEES OF BOSTON UNIVERSITY (US) 2022-06-16 WO disclosed
WO-2022006368-A2 TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF Life Technologies Corporation (US) 2022-01-06 WO disclosed
EP-1383480-A2 LIPID-COMPRISING DRUG DELIVERY COMPLEXES AND METHODS FOR THEIR PRODUCTION TARGETED GENETICS CORPORATION (US) 2004-01-28 EP disclosed
EP-1343371-A1 COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS INVITROGEN CORPORATION (US) 2003-09-17 EP disclosed
WO-2002088318-A2 LIPID-COMPRISING DRUG DELIVERY COMPLEXES AND METHODS FOR THEIR PRODUCTION TARGETED GENETICS CORPORATION (US) 2002-11-07 WO disclosed
WO-2002019822-A1 COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS INVITROGEN CORPORATION (US) 2002-03-14 WO disclosed
EP-0814777-A1 STABLE LIPID-COMPRISING DRUG DELIVERY COMPLEXES AND METHODS FOR THEIR PRODUCTION UNIVERSITY OF PITTSBURGH (US) 1998-01-07 EP disclosed
WO-1996022765-A1 STABLE LIPID-COMPRISING DRUG DELIVERY COMPLEXES AND METHODS FOR THEIR PRODUCTION UNIVERSITY OF PITTSBURGH (US) 1996-08-01 WO disclosed